Decreased Glucagon-Like Peptide 1 Receptor Expression in Endothelial and Smooth Muscle Cells in Diabetic Db/Db Mice: TCF7L2 Is a Possible Regulator of the Vascular Glucagon-Like Peptide 1 Receptor

Diabetes and Vascular Disease Research - United Kingdom
doi 10.1177/1479164117725898
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Science-Business eXchange
2009English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2016English

Synthesis and Biological Evaluation of Glucagon-Like Peptide-1 Receptor Agonists

Archives of Pharmacal Research
Organic ChemistryDrug DiscoveryMolecular Medicine
2013English

High Potency Antagonists of the Pancreatic Glucagon-Like Peptide-1 Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice

Physiology and Behavior
PhilosophyBehavioral NeuroscienceExperimentalCognitive Psychology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy